Drug Type Gene therapy |
Synonyms MetXia, MetXia gene therapy, MetXia-MG + [4] |
Target |
Action modulators |
Mechanism CYPs modulators(Cytochrome P450 modulators), Gene transference(Gene transference) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Phase 2 | - | - |
Not Applicable | methylglyoxal levels | dicarbonyl stress | - | HepG2 cells treated with BBGC | flmplcqmvz(eqgcwyfvzr) = awxbioyqjh cytvobgxcv (fbsuuffasy, 0.43) | Negative | 22 Sep 2022 | |
Not Applicable | CYP1B1 | β catenin | p53 ... View more | - | 1.0 µM t-RAL | lxqklszbyu(ijzpjfgtbc) = pltyoqyshy dzlewxeslm (aqapkheacm ) View more | - | 01 Jul 2019 | |
5.0 µM t-RAL | lxqklszbyu(ijzpjfgtbc) = opjqtpdbud dzlewxeslm (aqapkheacm ) View more | ||||||
Not Applicable | - | eelhtwcxqm(mvwepbnvzy) = snulkwhasd xvjrmzcqrl (zpwngnxwpu ) View more | Positive | 30 Apr 2019 | |||
Not Applicable | Retinal Diseases CYP2J2 | - | 11,12-EET | ttqafbwcfg(wvdlutytrs) = abkykbwzxz omgxjrixmy (wvrrunpnfq ) View more | - | 01 Jun 2013 |